Estrogen receptor B (ERB) is the predominant ER in the colorectal epithelium. Compared with normal colon tissue, ERB expression is reduced in colorectal cancer. Our hypothesis is that ERB inhibits proliferation of colon cancer cells. Hence, the aim of this study has been to investigate the molecular function of ERB in colon cancer cells, focusing on cell cycle regulation. SW480 colon cancer cells have been lentivirus transduced with ERB expression construct with or without mutated DNA-binding domain or an empty control vector. Expression of ERB resulted in inhibition of proliferation and G 1 phase cell cycle arrest and this effect was dependent on a functional DNA-binding region. c-Myc is overexpressed in an overwhelming majority of colorectal tumors. By Western blot and real-time PCR, we found c-Myc to be down-regulated in the ERB-expressing cells. Furthermore, the c-Myc target gene p21 (Waf1/Cip1) was induced and Cdc25A was reduced by ERB at the transcriptional level. The second cdk2-inhibitor, p27 Kip1 , was induced by ERB, but this regulation occurred at the posttranscriptional level, probably through ERB-mediated repression of the F-box protein p45 Skp2 . Expression of the ERB-variant with mutated DNA binding domain resulted in completely different cell cycle gene regulation. We performed in vivo studies with SW480 cells F ERB transplanted into severe combined immunodeficient/beige mice; after three weeks of ERB-expression, a 70% reduction of tumor volume was seen. Our results show that ERB inhibits proliferation as well as colon cancer xenograft growth, probably as a consequence of ERB-mediated inhibition of cell-cycle pathways. Furthermore, this ERB-mediated cell cycle repression is dependent on functional ERE binding. [Cancer Res 2009;69(15):6100-6]